Enforcement Report - Week of January 31, 2024
Dr Reddy's Laboratories Ltd announced the launch of the US Food and Drug Administration (FDA) approved cinacalcet tablets, a therapeutic equivalent generic version of Sensipar (cinacalcet) tablet.
HYDERABAD, India & PRINCETON, N.J.--(BUSINESS WIRE)--Dr. Reddy’s Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY, along with its subsidiaries together referred to as “Dr. Reddy’s”) today announced the launch of Cinacalcet Tablets, a therapeutic equivalent generic version of Sensipar (cinacalcet) Tablets, approved by the U.S. Food and Drug Administration (USFDA).
Acme Labs Generic Cinacalcet HCl Receives Approval in US
Accord Healthcare`s Generic Cinacalcet Receives Approval in Europe
Rumors that Amgen is looking to prop up its top and bottom lines by buying Alexion have been floating around for more than a year. Now, they’ve resurfaced, much to the delight of Wall Street analysts, who have been pressuring Amgen to do something to cushion the $2 billion in lost revenues it’s expected to suffer as key drugs like Neulasta and Sensipar fall to biosimilar competition.
A rumor that Amgen is closing in on buyout deal for Alexion has sparked a guessing game on just what kind of M&A strategy Amgen is pursuing and how much Alexion is worth.
Amgen is contending with some costly losses of exclusivity, and as sales for old stalwarts slide, the drugmaker is shifting its focus to a host of new launches in a bid to grow down the line.
LUPIN LTD`s generic CINACALCET HYDROCHLORIDE Receives Approval in US
Alkem Labs Generic Cinacalcet Hydrochloride Receives Approval in US